history of glp-1 agonists Discovery GLP-1–Based Drugs for the Treatment of Obesity history of glp-1 agonists A

Compare early results with Wegovy and Mounjaro.

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

Future research should focus on longitudinal dietary assessment, biomarker monitoring, and validation of standardized nutrition protocols for patients receiving GLP1-based obesity pharmacotherapy.

Learn About Their Benefits and Effectiveness.

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

Furthermore,...